Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 30,799 | 39,504 | 28,229 | 10,105 | 2,435 |
| Operating Income | -30,799 | -39,504 | -28,229 | -10,105 | -2,435 |
| Interest Expense | 19 | 34 | 0 | 0 | 1,453 |
| Other Income | 918 | 293 | -12 | 1,589 | 105 |
| Pre-tax Income | -29,899 | -39,244 | -28,241 | -8,516 | -3,783 |
| Income Tax | 20 | 17 | 21 | 6 | 1 |
| Net Income Continuous | -29,919 | -39,261 | -28,261 | -8,522 | -3,783 |
| Net Income | $-29,919 | $-39,261 | $-28,261 | $-8,522 | $-3,783 |
| EPS Basic Total Ops | -0.90 | -1.65 | -1.45 | -0.58 | -1.24 |
| EPS Basic Continuous Ops | -0.90 | -1.65 | -1.45 | -0.58 | -1.24 |
| EPS Diluted Total Ops | -0.90 | -1.65 | -1.45 | -0.58 | -1.24 |
| EPS Diluted Continuous Ops | -0.90 | -1.65 | -1.45 | -0.58 | -1.24 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -1.65 | -1.25 | -0.69 | -1.24 |
| EBITDA(a) | $-30,799 | $-39,504 | $-28,229 | $-10,105 | $-2,434 |